Southern Research makes key leadership announcements
November 12, 2020 | Southern Research
Southern Research has namedMichael Catalano andMark Suto, Ph.D., chief operating officer and vice president for Life Sciences, respectively. Previously, Catalano served as interim COO, and Suto was VP for Drug Discovery and interim VP for Drug Development.
“Michael and Mark have provided forward-thinking and effective leadership during this critical time of notable progress for SR and collaboration with UAB,” Watts said. “Solidifying these positions of leadership will enable SR to build on its strong trajectory and positive momentum.”
Catalano joined SR in 2017 as general counsel and assumed the interim COO role in 2018. As permanent COO, he will continue to manage the day-to-day operations of SR.
“I am honored to continue to serve in this role and humbled every day to work with our incredible teams at SR,” Catalano said. “I am proud of all we continue to accomplish together and excited about our future.”
Since joining SR in 2011, Suto has developed multiple research collaborations spanning a diverse array of diseases. In his new role, he will build on ongoing efforts to unite Drug Discovery and Drug Development to optimize growth in SR’s Life Sciences portfolio and impact.
“We have made great strides in evolving drug discovery and drug development in recent years as we ensure SR is well-positioned as a modern life sciences organization,” Suto said. “We have a bright future, and I am excited for this opportunity.”
Both promotions are effective immediately.
Prior to SR, Catalano was general counsel and privacy officer at Influence Health; chief operating officer, corporate secretary and general counsel for SilverStaff Inc.; vice president of finance for Caesars Entertainment Inc.; and senior development counsel for pharmacy health care provider CVS Caremark.
Suto has more than 35 years of experience working in several large pharmaceutical companies, as well as smaller biotech and venture-backed organizations. He has led multidisciplinary programs that resulted in the identification of clinical candidates in several therapeutic areas.
The Southern Research board of directors has expanded to 15 members, with new additions representing a diverse range of national expertise.
The new members were recently approved by the University of Alabama System Board of Trustees and will join the current board in May 2022.
“Southern Research ...
Southern Research today announced key additions to its staff and leadership team.
Brantley Fry has joined the organization as its new vice president of People and Community. Fry served as state director for former U.S. Sen. Doug Jones and most recently has worked as chief of staff and general cou...
Three weeks after I joined Southern Research as president and CEO, a 12-story condo building collapsed in Miami, killing 98 people and raising alarms about the structural integrity of buildings across the country. This tragedy led many organizations to take a hard look at the safety of their phys...